Pharma Intelligence is part of the Informa Intelligence Division of Informa PLC
This is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
Senior Reporter Pharma Insights
USA
+13 year(s) experience
Pink Sheet
The Cancer Drugs Fund has improved access to oncology drugs, but if it is to remain fit for purpose it will need to evolve.
Topic Cancer
Pink Sheet
England’s health technology appraisal body, NICE, and the UK medicines regulator, the MHRA, are working together to align their process timelines so that access to medicines is “maintained and enhanced.”
Topic Brexit Pharma-Brexit EU
Pink Sheet
Germany is for the first time to adopt national guidelines on prescribing biologics and biosimilars in move towards increasing biosimilar uptake.
Topic EU Biosimilars
Pink Sheet
The UK government has finally published its white paper on the UK’s future relationship with the EU following Brexit, to the relief of the pharmaceutical industry.
Topic Pharma-Brexit Brexit Regulation EU
Pink Sheet
A national pharmacare program in Canada could make it harder to access higher cost drugs.
Topic Policy and regulation
Pink Sheet
Latin American joint price negotiations have proved successful and other countries are taking note.
Pink Sheet
Regulatory harmonization is gathering pace in Latin America, which is good news for pharmaceutical companies.
Topic Policy and regulation
Pink Sheet
PRIMA, the new service the National Institute for Health and Care Excellence offers to review economic models, must not be affected by confidentiality and conflict of interest issues, warns UK the pharmaceutical industry group, ABPI.
Topic Business strategies
Pink Sheet
The UK government has finally published its white paper on the UK’s future relationship with the EU following Brexit, to the relief of the pharmaceutical industry.
Topic Brexit
Pink Sheet
The EU is once again facing criticism for its pursuit of investor-state dispute settlement-like mechanisms.
Pink Sheet
Health technology assessment agencies are struggling to evaluate drugs on the basis of evidence generated for early approvals.
Topic BioPharmaceutical
Scrip
In withdrawing its European marketing application for Translarna in cystic fibrosis, PTC Therapeutics has bid farewell to a market opportunity once pegged at $700m.
Pink Sheet
20 Jan 2021
Pink Sheet
19 Jan 2021
Pink Sheet
14 Jan 2021
Pink Sheet
13 Jan 2021
Pink Sheet
11 Jan 2021
Pink Sheet
10 Dec 2020
Pink Sheet
09 Dec 2020
Pink Sheet
08 Dec 2020
Pink Sheet
08 Dec 2020
Pink Sheet
04 Dec 2020
Pink Sheet
02 Dec 2020
In Vivo
02 Dec 2020
Pink Sheet
26 Nov 2020
Pink Sheet
12 Nov 2020
Generics Bulletin
26 Oct 2020
